Rate Benchmarking
Compare your rates with similar providers.
Select a published rate, define comparable providers, and see where that rate falls in your market.
See a sample rate comparisonHCPCS J3031 is classified under Drugs Administered Other than Oral Method, in the Drugs, Administered by Injection subgroup.
| Key Fact | Detail |
|---|---|
| Service Type | Drugs Administered Other than Oral Method Drugs, Administered by Injection |
| Common Place of Service | 11Office |
| Common Revenue Codes | 0636 |
| Medicaid Fee Schedule | $3.305 median of the 8 states in the free previewView Medicaid rates for J3031 |
| WAC Price | Lorem ipsum dolor sit amet consectetur Lorem ipsum dolor sit amet consectetur VisitBuyandBill.com |
| Related NDC Codes | • 51759020210 - AJOVY (fremanezumab-vfrm) 225 mg/1.5mL, injection • 51759020222 - AJOVY (fremanezumab-vfrm) 225 mg/1.5mL, injection • 51759020410 - AJOVY (fremanezumab-vfrm) 225 mg/1.5mL, injection |
National average reimbursement for HCPCS J3031 by major payers:

$3.39
BCBS / Anthem

$3.43
UnitedHealthcare

$3.42
Aetna

$3.23
Cigna
Choose a payer to see a sample of rates for HCPCS J3031.
Allina Health System, Allina Health Faribault Medical Center
Allina Health System
Banner Health, Banner Casa Grande Medical Center
Banner Health
Azita Taghavy
Azita Taghavy, A Professional Corp
Women And Infants Hospital
Women & Infants Hospital Of Rhode Island
Southeast Hospital, Mercy Hospital Southeast
Southeast Hospital
Choose your state and specialty to build a report from payer-published rates.
Looking for other data?
Rate Benchmarking
Select a published rate, define comparable providers, and see where that rate falls in your market.
See a sample rate comparisonPayer Contract Negotiation
Use your fee schedule and market benchmarks to set target rates and draft a letter for your payer.
See a sample payer proposalHCPCS J3031 vs. Other Drugs, Administered by Injection Codes
The table lists codes related to J3031. Select one to see its fee schedule.
| Code | Description |
|---|---|
| 51759020210-NDC | AJOVY (fremanezumab-vfrm) 225 mg/1.5mL, injection |
| 51759020222-NDC | AJOVY (fremanezumab-vfrm) 225 mg/1.5mL, injection |
| 51759020410-NDC | AJOVY (fremanezumab-vfrm) 225 mg/1.5mL, injection |
| J3031-HCPCS | Injection, fremanezumab-vfrm, 1 mg (code may be used for Medicare when drug administered under the direct supervision of a physician, not for use when drug is self-administered) |
What is a fee schedule?
A fee schedule is a list of fixed prices that healthcare providers charge for specific services, including HCPCS J3031. These prices vary depending on payer type (Medicare, Medicaid, private insurance), geographic location, and provider contracts.
Understanding the J3031 fee schedule helps patients estimate costs and providers optimize billing for accurate reimbursements.
Factors that affect fee schedules
Medicare & Medicaid Rates
Government-set reimbursement amounts
Private Insurance Rates
Negotiated rates between providers and insurance companies
Geographic Location
Costs may be higher in urban areas.
Provider Type
Hospital providers may have different rates than private practice.
Bring your top codes (like HCPCS J3031) and we'll show you how you compare in 15 minutes or less.
Hospital price transparency files list HCPCS J3031 under these revenue codes: 0636. A revenue code names the hospital department or charge category for the line; it does not change what the service is.